The Dermatologist’s Board Review - September 2018
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to http://www.galdermausa.com/Our-Commitment/PreBoard-Webinar.aspx.
1. Which of the following therapies is most likely to help this patient?
c) Ustekinumab (Stelara)
d) Interferon alpha
2. This teenager visits his primary care physician for a moderate case of tinea pedis. While examining his feet, the doctor notes a growth on this toe. The most likely diagnosis is:
a) Verruca vulgaris
b) Koenen tumor
e) Myxoid cyst
To learn the answers, go to page 2